secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-08-13T20:31:25+00:00
Accession:  0001193125-26-349334
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics enters $50M equity purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Up to $50M common stock purchase commitment; initial $25M available, auto-increases to $50M.
- Commitment fee: 560,356 shares issued immediately; 350,223 additional after full funding of initial $25M.
- Company controls timing/amount; regular purchases up to 60,000 shares (max $500k per purchase) at market-based prices.
- Lincoln Park capped at 4.99% beneficial ownership; no short sales; company can terminate with 1 business day notice.
- Exchange cap 19.99% unless stockholder approval or average price >= $1.3854 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526349334/0001193125-26-349334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526349334/d290418d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-349334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer